BIM

114.2

+0.79%↑

SRT3

229.2

+0.26%↑

GXI

54

+3.75%↑

ICAD

21.06

-1.5%↓

BIM

114.2

+0.79%↑

SRT3

229.2

+0.26%↑

GXI

54

+3.75%↑

ICAD

21.06

-1.5%↓

BIM

114.2

+0.79%↑

SRT3

229.2

+0.26%↑

GXI

54

+3.75%↑

ICAD

21.06

-1.5%↓

BIM

114.2

+0.79%↑

SRT3

229.2

+0.26%↑

GXI

54

+3.75%↑

ICAD

21.06

-1.5%↓

BIM

114.2

+0.79%↑

SRT3

229.2

+0.26%↑

GXI

54

+3.75%↑

ICAD

21.06

-1.5%↓

Search

Merck KGaA

Closed

119.7 -0.71

Overview

Share price change

24h

Current

Min

118.85

Max

120.7

Key metrics

By Trading Economics

Income

-142M

667M

Sales

152M

5.4B

P/E

Sector Avg

26.27

57.333

EPS

2.2

Dividend yield

1.34

Profit margin

12.311

EBITDA

85M

1.6B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+37.85% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.34%

2.63%

Next Earnings

15 maj 2025

Market Stats

By TradingEconomics

Market Cap

33B

98B

Previous open

120.41

Previous close

119.7

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

Merck KGaA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

6 mar 2025, 06:27 UTC

Earnings

Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results

11 lut 2025, 07:03 UTC

Acquisitions, Mergers, Takeovers

Germany's Merck in Talks to Buy SpringWorks Therapeutics

10 lut 2025, 16:38 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

SpringWorks Therapeutics Shares Rise on Report it May be Acquired

24 kwi 2025, 22:51 UTC

Top News
Acquisitions, Mergers, Takeovers

Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update

24 kwi 2025, 20:54 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA: No Final Decision Has Been Taken; No Legally Binding Agreement Has Been Entered Into

24 kwi 2025, 20:50 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA Confirms Late-Stage Discussions With SpringWorks Therapeutics on Potential Acquisition for About 47c a Share

24 kwi 2025, 19:05 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA Expected to Pay Close to $47 a Share for SpringWorks, Sources Say -- WSJ

24 kwi 2025, 19:05 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA, SpringWorks Deal Expected to Be Finalized as Soon as Monday, Sources Say -- WSJ

24 kwi 2025, 19:05 UTC

Top News
Acquisitions, Mergers, Takeovers

Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- WSJ

24 kwi 2025, 19:05 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA Nears Roughly $3.5 Billion Takeover of SpringWorks Therapeutics, Sources Say -- WSJ

6 mar 2025, 11:18 UTC

Market Talk
Earnings

Impact from U.S. Tariffs Is Manageable for Merck KGaA, CEO Says -- Market Talk

6 mar 2025, 11:14 UTC

Market Talk

Merck KGaA's Outlook Signals Greater Transparency -- Market Talk

6 mar 2025, 08:20 UTC

Market Talk
Earnings

Merck KGaA's Earnings Guidance Seems Soft Amid Semiconductor Uncertainty -- Market Talk

6 mar 2025, 06:00 UTC

Earnings

Merck KGaA Expects 2025 Net Sales Between EUR21.5B and EUR22.9B

6 mar 2025, 06:00 UTC

Earnings

Merck KGaA 2024 Adj EPS EUR8.63

6 mar 2025, 06:00 UTC

Earnings

Merck KGaA Expects 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B

6 mar 2025, 06:00 UTC

Earnings

Merck KGaA 2024 EBIT EUR3.645B

6 mar 2025, 06:00 UTC

Earnings

Merck KGaA 2024 After-Tax Profit EUR2.79B

6 mar 2025, 06:00 UTC

Earnings

Merck KGaA 2024 Ebitda Before One-Time Items EUR6.07B

6 mar 2025, 06:00 UTC

Earnings

Merck KGaA 2024 EBITDA EUR5.78B

6 mar 2025, 06:00 UTC

Earnings

Merck KGaA 2024 Sales EUR21.16B

6 mar 2025, 06:00 UTC

Earnings

Merck KGaA Keeps Dividend at EUR2.20

6 mar 2025, 06:00 UTC

Earnings

Analysts Saw Merck KGaA 2024 Sales at EUR21.14B

6 mar 2025, 06:00 UTC

Earnings

Analysts Saw Merck KGaA 2024 Ebitda Before One-Time Items at EUR6.08B

11 lut 2025, 16:45 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Merck's Potential Springworks Deal Unlikely to Move Needle on Earnings -- Market Talk

11 lut 2025, 10:54 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Germany's Merck Potential Buy of SpringWorks Therapeutics Puts Its Strategy Into Question -- Market Talk

11 lut 2025, 10:52 UTC

Market Talk
Acquisitions, Mergers, Takeovers

German Merck's Potential Buy of SpringWorks Therapeutics Holds Profitability Risk -- Market Talk

6 sty 2025, 13:08 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA: Transaction closed on Dec. 23, 2024

6 sty 2025, 13:07 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA: Didn't Disclose Financial Details

6 sty 2025, 13:06 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA: HUB's Organoid Offering Complements Merck KGaA's Cell Culture Portfolio

Peer Comparison

Price change

Merck KGaA Forecast

Price Target

By TipRanks

37.85% upside

12 Months Forecast

Average 166.25 EUR  37.85%

High 190 EUR

Low 107 EUR

Based on 9 Wall Street analysts offering 12 month price targets forMerck KGaA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

6

Buy

2

Hold

1

Sell

Technical Score

By Trading Central

117.55 / N/ASupport & Resistance

Short Term

Very Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Merck KGaA

There is no Profile data available for MRK.BE.